Kelman Lazarov Inc. bought a new stake in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,490 shares of the company’s stock, valued at approximately $448,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Addison Advisors LLC bought a new position in Merck KGaA in the second quarter valued at approximately $90,000. Comprehensive Financial Planning Inc. PA bought a new position in shares of Merck KGaA in the 2nd quarter valued at $134,000. Stevens Capital Partners acquired a new position in shares of Merck KGaA during the 2nd quarter worth $220,000. BOK Financial Private Wealth Inc. bought a new stake in shares of Merck KGaA during the 2nd quarter worth $523,000. Finally, one8zero8 LLC bought a new stake in shares of Merck KGaA during the 2nd quarter worth $830,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Stock Performance
OTCMKTS:MKGAF opened at $167.38 on Thursday. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock’s 50-day simple moving average is $162.50 and its 200 day simple moving average is $148.28. The firm has a market capitalization of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
